VIA-AVENIR 50 MG

Country: Israel

Language: English

Source: Ministry of Health

Active ingredient:

SILDENAFIL AS CITRATE

Available from:

BIOAVENIR LTD, ISRAEL

ATC code:

G04BE03

Pharmaceutical form:

FILM COATED TABLETS

Composition:

SILDENAFIL AS CITRATE 50 MG

Administration route:

PER OS

Prescription type:

Required

Manufactured by:

TECNIMEDE ESPANA INDUSTRIA FARMACEUTICA S.A., SPAIN

Therapeutic area:

SILDENAFIL

Therapeutic indications:

Treatment of erectile dysfunction.

Authorization date:

2017-02-28

Patient Information leaflet

PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS' REGULATIONS
(PREPARATIONS) - 1986
This medicine is dispensed with a doctor’s prescription only
VIA-AVENIR 25 MG
VIA-AVENIR 50 MG
VIA-AVENIR 100 MG
FILM-COATED TABLETS
Each tablet contains:
sildenafil (as citrate) 25 mg, 50 mg, 100 mg
Inactive ingredients and allergens in this medicine: see section 2
‘Important information about
some of this medicine's ingredients’ and section 6 ‘Additional
information’.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE. This leaflet contains
concise information about this medicine. If you have any further
questions, consult your doctor or
pharmacist.
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them, even if it
seems to you that their medical condition is similar to yours. This
medicine is intended for adults
over the age of 18 and is not intended for women.
1.
WHAT IS THIS MEDICINE INTENDED FOR?
Treatment of impotence - erectile dysfunction.
THERAPEUTIC GROUP:
PDE5 enzyme inhibitor, causes dilation of blood vessels, thereby
improving the blood flow into the
penis during sexual stimulation.
2.
BEFORE USING THIS MEDICINE
DO NOT USE THE MEDICINE IF:
•
you are sensitive (allergic) to the active ingredient or to any of the
other ingredients in this
medicine (see section 6).
•
you are intermittently or regularly taking organic nitrates, organic
nitrites, or nitric oxide
donors, such as amyl nitrite, in any form (such as certain medicines
for treating angina
pectoris).
•
you are concomitantly taking guanylate cyclase stimulators (such as
riociguat for treating
pulmonary hypertension).
•
you have a severe heart or liver disease.
•
you have recently had a stroke or a heart attack, or if you suffer
from low blood pressure.
•
you have a certain rare inherited eye disease (such as retinitis
pigmentosa).
•
you have or have had vision loss due to non-arteritic anterior
ischemic optic neuropathy
(NAION).
SPECIAL WARNINGS ABOUT USING THIS MEDICINE
BEFORE USING